322 related articles for article (PubMed ID: 15733211)
1. Prediction of drug metabolism and interactions on the basis of in vitro investigations.
Pelkonen O; Turpeinen M; Uusitalo J; Rautio A; Raunio H
Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):167-75. PubMed ID: 15733211
[TBL] [Abstract][Full Text] [Related]
2. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
Gómez-Lechón MJ; Castell JV; Donato MT
Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of drug interaction studies in drug development: the good, the bad, and the unknown.
Alfaro CL
Psychopharmacol Bull; 2001; 35(4):80-93. PubMed ID: 12397858
[TBL] [Abstract][Full Text] [Related]
4. Drug interactions evaluation: an integrated part of risk assessment of therapeutics.
Zhang L; Reynolds KS; Zhao P; Huang SM
Toxicol Appl Pharmacol; 2010 Mar; 243(2):134-45. PubMed ID: 20045016
[TBL] [Abstract][Full Text] [Related]
5. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
Lynch T; Price A
Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
[TBL] [Abstract][Full Text] [Related]
6. Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessment.
Venkatakrishnan K; Obach RS; Rostami-Hodjegan A
Xenobiotica; 2007; 37(10-11):1225-56. PubMed ID: 17968744
[TBL] [Abstract][Full Text] [Related]
7. Predicting in vivo drug interactions from in vitro drug discovery data.
Wienkers LC; Heath TG
Nat Rev Drug Discov; 2005 Oct; 4(10):825-33. PubMed ID: 16224454
[TBL] [Abstract][Full Text] [Related]
8. Prediction of CYP-mediated drug interactions in vivo using in vitro data.
Foti RS; Wahlstrom JL
IDrugs; 2008 Dec; 11(12):900-5. PubMed ID: 19051152
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes.
Touw DJ
Drug Metabol Drug Interact; 1997; 14(2):55-82. PubMed ID: 9893738
[TBL] [Abstract][Full Text] [Related]
10. Human hepatocytes: isolation, cryopreservation and applications in drug development.
Li AP
Chem Biol Interact; 2007 May; 168(1):16-29. PubMed ID: 17270162
[TBL] [Abstract][Full Text] [Related]
11. Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism.
Muruganandan S; Sinal CJ
Clin Pharmacol Ther; 2008 Jun; 83(6):818-28. PubMed ID: 18388875
[TBL] [Abstract][Full Text] [Related]
12. Designing better drugs: predicting cytochrome P450 metabolism.
de Groot MJ
Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. Predicting inhibitory drug-drug interactions and evaluating drug interaction reports using inhibition constants.
Bachmann KA; Lewis JD
Ann Pharmacother; 2005 Jun; 39(6):1064-72. PubMed ID: 15886285
[TBL] [Abstract][Full Text] [Related]
15. [Study of hepatic drug metabolism. For a rationalization of a new molecular development].
Le Dinh T; Christoforov B
Therapie; 1994; 49(2):133-40. PubMed ID: 7817337
[TBL] [Abstract][Full Text] [Related]
16. Use of physiologically based pharmacokinetic modeling for assessment of drug-drug interactions.
Baneyx G; Fukushima Y; Parrott N
Future Med Chem; 2012 Apr; 4(5):681-93. PubMed ID: 22458685
[TBL] [Abstract][Full Text] [Related]
17. Drug metabolism and drug interactions in the elderly.
Herrlinger C; Klotz U
Best Pract Res Clin Gastroenterol; 2001 Dec; 15(6):897-918. PubMed ID: 11866484
[TBL] [Abstract][Full Text] [Related]
18. MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist.
Cruciani G; Carosati E; De Boeck B; Ethirajulu K; Mackie C; Howe T; Vianello R
J Med Chem; 2005 Nov; 48(22):6970-9. PubMed ID: 16250655
[TBL] [Abstract][Full Text] [Related]
19. ADMET--Fifth Annual SMi Conference.
Comer JE
IDrugs; 2010 Sep; 13(9):610-4. PubMed ID: 20799141
[TBL] [Abstract][Full Text] [Related]
20. In vitro metabolic interaction studies: experience of the Food and Drug Administration.
Yuan R; Parmelee T; Balian JD; Uppoor RS; Ajayi F; Burnett A; Lesko LJ; Marroum P
Clin Pharmacol Ther; 1999 Jul; 66(1):9-15. PubMed ID: 10430104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
